In conclusion, our study using ob/ob mice has shown that inhibition of hepatic GRK2 expression is sufficient to improve glucose homeostasis and insulin sensitivity, which eventually improves endothelial dysfunction in T2DM. This evidence concerns the gene GRK2 and endothelial dysfunction.